News – Page 2 – De Motu Cordis Pty Ltd

News

De Motu Cordis Expands Global IP Portfolio

By dev|2026-08-17T05:11:44+00:00February 18, 2025|Categories: News|

De Motu Cordis (DMC) receives a letter of support from Food Allergy Research and Education (FARE)

By dev|2026-08-17T05:11:45+00:00November 1, 2024|Categories: News|

The List: Top 100 Innovators 2024

By rpadmin|2024-10-20T09:18:12+00:00October 20, 2024|Categories: News|

De Motu Cordis (DMC) Applauds ARS Pharma’s FDA Approval of Neffy®, Expanding Patient Options to Needle-Free Epinephrine Delivery and Inspiring Confidence in Our Own Development Efforts.

By dev|2026-08-17T05:11:46+00:00August 16, 2024|Categories: News|

De Motu Cordis (DMC) announces plans for the next stage of development for DMC-IH1, an inhaled epinephrine drug device combination product

By dev|2026-08-17T05:11:47+00:00July 17, 2024|Categories: News|

Forbes magazine features DMC founder – how Professor John Fraser aims to ensure that through innovation, patients thrive, not just survive

By dev|2026-08-17T05:11:48+00:00March 6, 2024|Categories: News|

BiVacor Receives Grant to Support Clinical Trials for Total Artificial Heart

By rpadmin|2024-02-20T16:57:02+00:00February 20, 2024|Categories: News|

DMC Director, Doctor Glen Richards, a 2023 UQ Alumni Award winner!

By dev|2026-08-17T05:11:49+00:00November 6, 2023|Categories: News|

BEDA MedTech official ambassador

By rpadmin|2023-06-16T18:02:52+00:00June 16, 2023|Categories: News|

De Motu Cordis (DMC) welcomed Queensland Treasurer and Minister for Trade and Investment Honourable Cameron Dick MP

By dev|2026-08-17T05:11:50+00:00April 4, 2023|Categories: News|

Previous 123 Next